Cipla has launched Yurpeak, a new injectable medication for obesity and type-2 diabetes. This one-weekly therapy, tirzepatide, is now available in India. Yurpeak aims to address two significant health challenges in the country. Cipla is collaborating with Eli Lilly for this innovative treatment. The drug will be offered in multiple strengths.

See Full Page